Isabell Wiethoff
7PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 19, 2025
Model-Based Economic Evaluation of the First-in-Class Myosin Inhibitor Mavacamten Versus Care as Usual in Obstructive Hypertrophic Cardiomyopathy Patients from a Dutch Societal Perspective.Isabell Wiethoff, Willem J A Witlox, Silvia M A A Evers
|May 28, 2025
Assessing the psychometric properties of generic (EQ-5D-5L) and disease-specific (KCCQ) quality of life in patients with hypertrophic cardiomyopathy in the AFFECT-HCM study.Isabell Wiethoff, Stephan A C Schoonvelde, Rudolf A de Boer
|Nov 09, 2024
Loss of quality of life and increased societal costs in patients with hypertrophic cardiomyopathy: the AFFECT-HCM study.Stephan A C Schoonvelde, Isabell Wiethoff, Peter-Paul Zwetsloot
|Sep 14, 2023
Quality of life and societal costs in patients with dilated cardiomyopathy.Isabell Wiethoff, Maurits Sikking, Silvia Evers
|May 12, 2023
A systematic literature review of economic evaluations and cost-of-illness studies of inherited cardiomyopathies.Isabell Wiethoff, Birgit Goversen, Michelle Michels
|May 12, 2023
An introduction to health technology assessment and health economic evaluation: an online self-learning course.Isabell Wiethoff, Silvia M A A Evers, Michelle Michels
Pageof 2
Frequent Collaborators
3 joint publications
Silvia M A A Evers
3 joint publications
Michelle Michels
2 joint publications
Maurits Sikking
2 joint publications
Tjeerd Germans
2 joint publications
Mickaël Hiligsmann
2 joint publications
Stephan A C Schoonvelde
2 joint publications
Christian Knackstedt
2 joint publications
Alexander Hirsch
1 joint publications
Willem J A Witlox
1 joint publications
Michiel Henkens
